Lineage Cell Therapeutics, Inc. 10-K Cybersecurity GRC - 2024-03-07

Page last updated on July 16, 2024

Lineage Cell Therapeutics, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-07 16:21:06 EST.


10-K filed on 2024-03-07

Lineage Cell Therapeutics, Inc. filed a 10-K at 2024-03-07 16:21:06 EST
Accession Number: 0000950170-24-027988

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

Company Information

NameLineage Cell Therapeutics, Inc.
SIC DescriptionBiological Products, (No Diagnostic Substances)
CategoryNon-accelerated filer
Smaller reporting company
Fiscal Year EndDecember 30